Literature DB >> 21128598

OCT2 and MATE1 provide bidirectional agmatine transport.

Tate N Winter1, William F Elmquist, Carolyn A Fairbanks.   

Abstract

Agmatine is a biogenic amine (l-arginine metabolite) of potential relevance to several central nervous system (CNS) conditions. The identities of transporters underlying agmatine and polyamine disposition in mammalian systems are not well-defined. The SLC-family organic cation transporters (OCT) OCT1 and OCT2 and multidrug and toxin extrusion transporter-1 (MATE1) are transport systems that may be of importance for the cellular disposition of agmatine and putrescine. We investigated the transport of [(3)H]agmatine and [(3)H]putrescine in human embryonic kidney (HEK293) cells stably transfected with hOCT1, hOCT2, and hMATE1. Agmatine transport by hOCT1 and hOCT2 was concentration-dependent, whereas only hOCT2 demonstrated pH-dependent transport. hOCT2 exhibited a greater affinity for agmatine (K(m) = 1.84 ± 0.38 mM) than did hOCT1 (K(m) = 18.73 ± 4.86 mM). Putrescine accumulation was pH- and concentration-dependent in hOCT2-HEK cells (K(m) = 11.29 ± 4.26 mM) but not hOCT1-HEK cells. Agmatine accumulation, in contrast to putrescine, was significantly enhanced by hMATE1 overexpression, and was saturable (K(m) = 240 ± 31 μM; V(max) = 192 ± 10 pmol/min/mg of protein). Intracellular agmatine was also trans-stimulated (effluxed) from hMATE1-HEK cells in the presence of an inward proton-gradient. The hMATE1-mediated transport of agmatine was inhibited by polyamines, the prototypical substrates MPP+ and paraquat, as well as guanidine and arcaine, but not l-arginine. These results suggest that agmatine disposition may be influenced by hOCT2 and hMATE1, two transporters critical in the renal elimination of xenobiotic compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128598      PMCID: PMC4589871          DOI: 10.1021/mp100180a

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  60 in total

1.  Agmatine improves locomotor function and reduces tissue damage following spinal cord injury.

Authors:  C G Yu; A E Marcillo; C A Fairbanks; G L Wilcox; R P Yezierski
Journal:  Neuroreport       Date:  2000-09-28       Impact factor: 1.837

2.  rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.

Authors:  D H Sweet; J B Pritchard
Journal:  Am J Physiol       Date:  1999-12

3.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

4.  Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.

Authors:  Anna Kruczynski; Isabelle Vandenberghe; Arnaud Pillon; Sabrina Pesnel; Liliane Goetsch; Jean-Marc Barret; Yves Guminski; Alain Le Pape; Thierry Imbert; Christian Bailly; Nicolas Guilbaud
Journal:  Invest New Drugs       Date:  2009-09-24       Impact factor: 3.850

Review 5.  The polyamine transport system as a target for anticancer drug development.

Authors:  Andrew J Palmer; Heather M Wallace
Journal:  Amino Acids       Date:  2009-12-03       Impact factor: 3.520

6.  Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.

Authors:  Henriette E Meyer zu Schwabedissen; Celine Verstuyft; Heyo K Kroemer; Laurent Becquemont; Richard B Kim
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06

7.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

Authors:  Y Urakami; M Okuda; S Masuda; H Saito; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

Review 8.  Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain.

Authors:  D J Reis; S Regunathan
Journal:  J Auton Nerv Syst       Date:  1998-10-15

9.  Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance.

Authors:  Carrie L Wade; Lori L Eskridge; H Oanh X Nguyen; Kelley F Kitto; Laura S Stone; George Wilcox; Carolyn A Fairbanks
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

10.  Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.

Authors:  Yuko Tanihara; Satohiro Masuda; Tomoko Sato; Toshiya Katsura; Osamu Ogawa; Ken-Ichi Inui
Journal:  Biochem Pharmacol       Date:  2007-04-13       Impact factor: 5.858

View more
  20 in total

Review 1.  Recent advances in the molecular biology of metazoan polyamine transport.

Authors:  R Poulin; R A Casero; D Soulet
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.

Authors:  Obinna N Obianom; Ana L Coutinho; Wei Yang; Hong Yang; Fengtian Xue; Yan Shu
Journal:  Mol Pharm       Date:  2017-07-21       Impact factor: 4.939

Review 4.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

5.  Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.

Authors:  Monica Sala-Rabanal; Dan C Li; Gregory R Dake; Harley T Kurata; Mikhail Inyushin; Serguei N Skatchkov; Colin G Nichols
Journal:  Mol Pharm       Date:  2013-03-19       Impact factor: 4.939

Review 6.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

7.  Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.

Authors:  Carolien M S Schophuizen; Martijn J Wilmer; Jitske Jansen; Lena Gustavsson; Constanze Hilgendorf; Joost G J Hoenderop; Lambert P van den Heuvel; Rosalinde Masereeuw
Journal:  Pflugers Arch       Date:  2013-06-29       Impact factor: 3.657

Review 8.  Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.

Authors:  C Arimany-Nardi; H Koepsell; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-11-03       Impact factor: 3.550

9.  Functional characterization of fission yeast transcription factors by overexpression analysis.

Authors:  Lianne Vachon; Justin Wood; Eun-Joo Gina Kwon; Amy Laderoute; Kate Chatfield-Reed; Jim Karagiannis; Gordon Chua
Journal:  Genetics       Date:  2013-05-20       Impact factor: 4.562

10.  A metabolomics pipeline for the mechanistic interrogation of the gut microbiome.

Authors:  Shuo Han; Will Van Treuren; Curt R Fischer; Bryan D Merrill; Brian C DeFelice; Juan M Sanchez; Steven K Higginbottom; Leah Guthrie; Lalla A Fall; Dylan Dodd; Michael A Fischbach; Justin L Sonnenburg
Journal:  Nature       Date:  2021-07-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.